News
Filter
-
AbbVie acquires LifeArc portfolio company DJS Antibodies
-
LifeArc’s new fund to advance gene-based medicines for genetic diseases
-
New toolkit launched to help repurposed medicines reach patients
-
LifeArc scientist awarded prestigious industrial fellowship
-
LifeArc joins forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to strengthen antimicrobial discovery efforts
-
Aisling Burnand CBE, 1964-2022
-
Separate science from politics: save the UK’s science sector
-
Promising new antibody treatment for osteoporosis and multiple sclerosis
-
Her Majesty Queen Elizabeth II
-
LifeArc portfolio company Ducentis BioTherapeutics acquired by Arcutis Biotherapeutics for up to $400 million
-
Seven questions about LifeArc’s 2030 ambitions
-
LifeArc helps create new MRC spin-out company
